参考文献

1.李少林，王荣福．核医学．第8版．北京：人民卫生出版社，2013.

2.安锐，黄钢．核医学．第3版．北京：人民卫生出版社，2015.

3.王志刚．超声分子影像学研究进展．中国医学影像技术，2009，25（6）：921-924.

4.钱梦騄，程茜，周红生．超声分子成像进展．应用声学，2013，32（3）：182-189.

5.王培军，沈爱军．分子影像学探针的研究现状与展望．中国医学影像技术，2017，33（10）：1445-1446.

6.张龙江，祁吉．分子影像学报告基因显像的研究进展．中国医学影像技术，2005，21（11）：1772-1775.

7.James M L，Gambhir S S. A molecular imaging primer：modalities，imaging agents，and applications. Physiological Reviews，2012，92（2）：897-965.

8.Weissleder R，Mahmood U. Molecular imaging. Radiology，2001，219：316-333.

9.Pysz MA，Machtaler SB，Seeley ES，et al. Vascular Endothelial Growth Factor Receptor Type 2-targeted Contrast-enhanced US of Pancreatic Cancer. Radiology，2015，274（3）：790-799.

10.Kim J Y，Lee S H，Kim S，et al. Tumour 18F-FDG Uptake on preoperative PET/CT may predict axillary lymph node metastasis in ER-positive/HER2-negative and HER2-positive breast cancer subtypes. European Radiology，2015，25（4）：1172-1181.

11.Sampson JH，Choi BD，Sanchez-Perez L，et al. EGFRvIII mCAR -modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss. Clin Cancer Res，2014，20（4）：972-984.

12.Luo H，Hernandez R，Hong H，et al. Noninvasive brain cancer imaging with a bispecific antibody fragment，generated via click chemistry. Proc Natl Acad Sci U S A，2015，112（41）：12806-12811.

13.Dai D，Xu W，Liu J，et al. Safety and efficacy of a peripheral intravenous bolus of Licartin for the treatment of advanced hepatocellular carcinoma. Experimental & Therapeutic Medicine，2013，6（6）：1417-1422.

14.Zha Z，Yue X，Ren Q，et al. Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells. Advanced Materials，2013，25（5）：777-782.

15.Lee H，Lyttonjean A K，Chen Y，et al. Molecularly selfassembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nature Nanotechnology，2013，7（6）：389-393.

16.Jokerst J V，Gambhir S S. Molecular Imaging with Theranostic Nanoparticles. Acc Chem Res，2011，44（10）：1050-1060.

17.Badr CE. Bioluminescence imaging：basics and practical limitations. Methods Mol Biol，2014，1098：1-18.

18.Yao Z，Zhang BS，Prescher JA. Advances in bioluminescence imaging：new probes from old recipes. Current Opinion in Chemical Biology，2018，45：148-156.

19.Zhao J，Zhong D，Zhou S. NIR-I-to-NIR-II fluorescent nanomaterials for biomedical imaging and cancer therapy.Journal of Materials Chemistry B，2018，6（3）：349-365.

20.Ding F，Zhan Y，Lu X，et al. Recent advances in near-infrared II fluorophores for multifunctional biomedical imaging.Chem Sci，2018，9（19）：4370-4380.

21.Boccara AC，Dubois A. Optical Coherence Tomography.Optics in Instruments，2013.

22.de Carlo TE，Romano A，Waheed NK，et al. A review of optical coherence tomography angiography（OCTA）．Int J Retina Vitreous，2015，1：5.

23.Si P，Yuan E，Liba O，et al. Gold nanoprisms as optical coherence tomography contrast agents in the second nearinfrared window for enhanced angiography in live animals.ACS Nano，2018.

24.Zavaleta CL，Kircher MF，Gambhir SS. Raman’s “effect”on molecular imaging. J Nucl Med，2011，52（12）：1839-1844.

25.Stewart S，Priore RJ，Nelson MP，et al. Raman imaging.Annu Rev Anal Chem，2012，5：337-360.

26.Wang LV，Yao J. A practical guide to photoacoustic tomography in the life sciences. Nature Methods，2016，13（8）：627-638.

27.Weber J，Beard PC，Bohndiek S E. Contrast agents for molecular photoacoustic imaging. Nature Methods，2016，13（8）：639-650.

28.Xu Y，Liu H，Cheng Z. Harnessing the Power of Radionuclides for Optical Imaging：Cerenkov Luminescence Imaging. Journal of Nuclear Medicine，2011，52（12）：2009-2018.

29.Demers JL，Davis SC，Zhang R，et al. Čerenkov excited fluorescence tomography using external beam radiation.Optics Letters，2013，38（8）：1364-1366.

30.Zhang W，Shen Y，Liu M，et al. Sub-10 nm Water-Dispersible β-NaGdF4：X% Eu3 + Nanoparticles with Enhanced Biocompatibility for in Vivo X-ray Luminescence Computed Tomography. ACS Applied Materials & Interfaces，2017，9（46）：39985-39993.

31.Hu Z，Qu Y，Wang K，et al. In vivo nanoparticle-mediated radiopharmaceuticalexcited fluorescence molecular imaging. Nature Communications，2015，6：7560.

32.Zhang PC，Cui YG，Anderson CF，et al. Peptide-based nanoprobes for molecular imaging and disease diagnostics.Chem Soc Rev，2018，47：3490-3529.

33.Blasberg RG，Tjuvajev JG. Molecular-genetic imaging：current and future perspectives. J Clin Invest，2003，111：1620-1629.

34.Demetri GD，Mehren MV，Blanke CD，et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med，2002，347：472-480.

35.Naumova AV，Velde G V. Genetically encoded iron-associated proteins as MRI reporters for molecular and cellular imaging. WIRES NanomedNanobiotechnol，2018，10（2）：e1482.

36.Kunth M，Lu GJ，Witte C，et al. Protein nanostructures produce self-adjusting hyperpolarized magnetic resonance imaging contrast through physical gas partitioning. ACS Nano，2018，DOI：10.1021/acsnano.8b04222.

37.Tsvirkun D，Ben-Nun Y，Merquiol E，et al. CT imaging of enzymatic activity in cancer using covalent probes reveal a size-dependent pattern. J Am Chem Soc，2018，DOI：10.1021/jacs.8b05817.

38.Shi HY，Wang ZM，Huang CS，et al. A functional CT contrast agent for in vivo imaging of tumor hypoxia. Small，2016，12（29）：3995-4006.

39.Xue ZL，Yi ZG，Li XL，et al. Upconversion optical/magnetic resonance imaging-guided small tumor detection and in vivo tri-modal bioimaging based on high-performance luminescent nanorods. Biomaterials，2017，115：90-103.

40.Xiao QF，Bu WB，Ren QG，et al. Radiopaque fluorescencetransparent TaOx decorated upconversion nanophosphors for in vivo CT/MR/UL trimodal imaging. Biomaterials，2012，33（30）：7530-7539.

41.Shang WT，Zeng CT，Du Y，et al. Core-Shell gold nanorod@metal-organic framework nanoprobes for multimodality diagnosis of glioma. Advan Mater，2017，29（3）：1604381.

42.Rowe SP，Gage KL，Faraj SF，et al. 18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer. J Nucl Med，2015，56（7）：1003.

43.Blanco E，Shen H，Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery.Nat Biotechnol，2015，33（9）：941.

44.Bousso P，Moreau HD. Functional immunoimaging：the revolution continues. Nat Rev Immunol，2012，12（12）：858-864.

45.Ashkenazi A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev，2008，19（3-4）：325-331.

46.Murakami Y，Takamatsu H，Taki J，et al. 18F-labelled annexin V：a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging，2004，31（4）：469-474.

47.Didiot MC，Ferguson CM，Ly S，et al. Nuclear Localization of Huntingtin mRNA Is Specific to Cells of Neuronal Origin. Cell Rep，2018，24（10）：2553-2560.

48.Mukherjee A，Wu D，Davis HC，et al. Non-invasive imaging using reporter genes altering cellular water permeability.Nat Commun，2016，7：13891.